BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 845790)

  • 1. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.
    Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Spiegel HE; Symington J; Christian R; Moore JD; Weissman L; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Feb; 5(1):3-23. PubMed ID: 845790
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.
    Boxenbaum HG; Geitner KA; Jack ML; Dixon WR; Kaplan SA
    J Pharmacokinet Biopharm; 1977 Feb; 5(1):25-39. PubMed ID: 845789
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption of oral and intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM; Franke K; Giles HG
    Eur J Clin Pharmacol; 1978 Jun; 13(4):267-74. PubMed ID: 668784
    [No Abstract]   [Full Text] [Related]  

  • 4. Slow absorption of intramuscular chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    N Engl J Med; 1974 Nov; 291(21):1116-8. PubMed ID: 4416981
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption of oral intramuscular chlordiazepoxide by alcoholics.
    Perry PJ; Wilding DC; Fowler RC; Hepler CD; Caputo JF
    Clin Pharmacol Ther; 1978 May; 23(5):535-41. PubMed ID: 639427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM
    Clin Pharmacokinet; 1978; 3(5):381-94. PubMed ID: 359214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular injections and bioavailability.
    Tuttle CB
    Am J Hosp Pharm; 1977 Sep; 34(9):965-8. PubMed ID: 333911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of drugs administered intramuscularly.
    Thomas J
    Aust Fam Physician; 1977 Aug; 6(8):925-34. PubMed ID: 921622
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological half-life of chlordiazepoxide and its metabolite, demoxepam, in man.
    Schwartz MA; Postma E; Gaut Z
    J Pharm Sci; 1971 Oct; 60(10):1500-3. PubMed ID: 5129365
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations.
    Gottschalk LA; Biener R; Dinovo EC
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):697-702. PubMed ID: 4607746
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic determinants of the response to single doses of chlordiazepoxide.
    Greenblatt DJ; Shader RI; Koch-Weser J
    Am J Psychiatry; 1974 Dec; 131(12):1395-7. PubMed ID: 4432941
    [No Abstract]   [Full Text] [Related]  

  • 12. Alcohol and the benzodiazepines. The interaction between intravenous ethanol and chlordiazepoxide and diazepam.
    Dundee JW; Howard AJ; Isaac M
    Q J Stud Alcohol; 1971 Dec; 32(4):960-8. PubMed ID: 5137095
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).
    Roberts RK; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1978 Sep; 75(3):479-85. PubMed ID: 680505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The absorption of intramuscular chlordiazepoxide (Librium) in patients with severe alcoholic liver disease.
    Robinson JD; Whitney HA; Guisti DL; Morgan DD; Mendenhall CL
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):433-8. PubMed ID: 6629548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of benzodiazepine pharmacokinetics.
    Shader RI; Greenblatt DJ
    Am J Psychiatry; 1977 Jun; 134(6):652-6. PubMed ID: 17302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic model for chlordiazepoxide--HCl in the dog.
    Kaplan SA; Lewis M; Schwartz MA; Postma E; Cotler S; Abruzzo CW; Lee TL; Weinfeld RE
    J Pharm Sci; 1970 Nov; 59(11):1569-74. PubMed ID: 5495479
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic procedures in cases of severe delirium tremens].
    Góraj A
    Psychiatr Pol; 1975; 9(1):71-6. PubMed ID: 1090965
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers.
    Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC
    Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.
    Greenblatt DJ; Shader RI; Harmatz JS; Franke K; Koch-Weser J
    Am J Psychiatry; 1977 May; 134(5):559-62. PubMed ID: 848586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
    Wilkinson GR
    Acta Psychiatr Scand Suppl; 1978; (274):56-74. PubMed ID: 32740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.